Adocia
Latest round
- Series B
Last raised
- Jan 2010
Total raised
- $37M
Investors
- 9
About Adocia
Founded in 2005 and headquartered in Lyon, France, Adocia specializes in biopharmaceutical innovations for diabetes management and obesity. The company, founded by Olivier Soula, has undergone significant developments, including its IPO in March 2012, to expand its research and commercialization efforts.Adocia specializes in the development of innovative treatments primarily for diabetes and obesity, focusing on the formulation of advanced insulins and metabolic hormones. Their core product offerings include proprietary formulations that enhance the efficacy and usability of already-approved peptides and proteins, as well as immunoprotective scaffolds designed for cell therapies. These products are intended to improve glycemic control and weight management for patients suffering from type 1 and type 2 diabetes, alongside obesity-related metabolic issues.3.Adocia's strategy for future growth includes the development and launch of new products aimed at enhancing treatment options for diabetes and obesity. The company plans to further expand its market reach in Europe and North America within the next few years.
Who invested in Adocia
9 investors across 2 rounds
See all investors in Adocia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adocia
Who invested in Adocia?
Adocia has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adocia raised?
Adocia has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Adocia last raise money?
Adocia's most recent round on record is a Series B, in Jan 2010.
What does Adocia do?
Founded in 2005 and headquartered in Lyon, France, Adocia specializes in biopharmaceutical innovations for diabetes management and obesity.
Where is Adocia headquartered?
Adocia is headquartered in Lyon, France.
Which VCs invest in companies like Adocia?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Adocia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Adocia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.